Matias Nisenson

Matias Nisenson is a General Partner and co-founder at Myelin VC, an early-stage venture capital firm that partners with technology founders across various global markets. Since co-founding the investment vehicle in 2019 alongside prominent industry partners Martin Varsavsky and Alec Oxenford, he has helped direct capital allocations into a diverse portfolio of 26 technology companies. Operating primarily as an industry-agnostic institutional investor, Nisenson targets seed and Series A funding rounds, deploying capital with typical transaction ticket sizes ranging from €100,000 to €1,500,000 per deal. His portfolio management track record includes overseeing successful financial exits from notable healthcare and technology startups such as Aura Biosciences and Apryl. Drawing upon his prior operational background as a founder-turned-investor, Nisenson currently focuses on backing early-stage entrepreneurs who leverage technical innovation and scientific advances to build highly defensible market positions.